Actively Recruiting
Evaluation of Prototype Solutions to Improve Institutional Delivery, Antenatal Care, and Iron-Folic Acid Supplementation Among Pregnant Women in Ethiopia
Led by Johns Hopkins Bloomberg School of Public Health · Updated on 2025-11-18
1024
Participants Needed
1
Research Sites
35 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
B
Bill and Melinda Gates Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are conducting a three-year project to develop and test new ways to improve important health behaviors among pregnant women in Ethiopia. The study focuses on increasing the number of women delivering in health facilities, attending antenatal care (ANC) visits, and taking iron-folic acid supplements. It uses a Human-Centered-Design (HCD) approach to create solutions that better meet the needs of pregnant women and encourage their use of maternal and child health services. The study has two phases. In the first phase, a design sprint workshop will create initial prototype solutions, such as social and behavior change campaigns using print, radio, social media, and community events. These high-fidelity prototypes will be tested for four months. The second phase will further refine these solutions through extended HCD and implement them in two geographic areas for another four months. The study compares groups receiving the intervention package alongside usual care with groups receiving usual care only. Participants will be assessed at three times: baseline, midline (both in year 1), and end-line (in year 3). Pregnant women will complete surveys to measure changes in institutional delivery and ANC visits. The study will also include interviews to understand psychosocial effects and other outcomes. The study runs until June 2026 and is sponsored by the Johns Hopkins Bloomberg School of Public Health.
CONDITIONS
Brief Title
Evaluation of Prototype Solutions for Optimizing Maternal Health Behaviors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant for 5 or more months
- Female aged 15 to 49 years
- Moderate to high vulnerability
You will not qualify if you...
- Pregnant less than 5 months
- Not of reproductive age
- Low vulnerability
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 months
Participants in the intervention arm receive a package of behavioral interventions including social and behavior change communication campaigns tailored to their needs, alongside usual care. Participants in the control arm receive usual care only.
Regular interactions with intervention activities over 4 months
Duration - Up to 3 years with assessments at baseline, midline, and end-line
Participants complete baseline, midline, and end-line survey assessments to evaluate the effectiveness of the interventions on institutional delivery rates and antenatal care uptake.
3 assessment visits over the study period
Trial Site Locations
Total: 1 location
1
Center for Communication Programs
Addis Ababa, Ethiopia
Actively Recruiting
Research Team
R
Rajiv Rimal, PhD
B
Bee-Ah Kang, MSPH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here